Trials / Completed
CompletedNCT01546649
A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Takeda · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Hormone dynamics, pharmacokinetics, safety, and efficacy of TAP-144-SR(6M) will be evaluated against TAP-144-SR(3M) in postoperative and hormone therapy-naïve patients with premenopausal breast cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAP-144-SR(6M) | |
| DRUG | TAP-144-SR(3M) |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2012-03-07
- Last updated
- 2015-11-26
- Results posted
- 2015-11-26
Locations
15 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01546649. Inclusion in this directory is not an endorsement.